🇪🇺 Chemsex Addiction Treatment · France

Chemsex—the use of drugs like methamphetamine, GHB, and mephedrone to facilitate or enhance sexual activity—is a growing concern across Europe. In France, it presents distinct challenges for gay, bisexual, and other men who have sex with men (GBMSM). At European Addiction Centers (EAC), we connect you with accredited partner clinics across France offering specialised, evidence-based care. According to the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), chemsex-related emergency department visits have risen sharply in recent years. Our service provides a discreet, medically supervised path to recovery, tailored to your needs. Learn more about our approach to Chemsex Addiction Treatment.

Chemsex is not a niche issue in France; it is a public health concern with measurable impact. The French Observatory for Drugs and Addictive Tendencies (OFDT) reported that approximately 11% of GBMSM surveyed in Paris and Lyon had engaged in chemsex in the previous year. A 2022 EMCDDA study across several European cities, including Paris, found that 20% of HIV-positive men who inject drugs had used chemsex substances in the past month. These figures underscore a significant, often hidden, problem.

Legally, the substances used in chemsex—such as GHB, GBL, crystal meth, and cathinones—are prohibited in France under the Public Health Code. Possession and supply carry criminal penalties. However, the French public health system increasingly adopts a harm-reduction approach, with specialised clinics in cities like Paris, Marseille, and Bordeaux offering targeted support. Despite this, stigma remains a barrier: fear of judgement or legal consequences deters many from seeking help. Cultural factors, including the high value placed on discretion in French professional life, often delay treatment. For those ready to act, we connect you with rehab centres in France that offer private, confidential care away from local pressures.

Chemsex addiction is characterised by a compulsive pattern of drug use specifically linked to sexual activity. Signs include using alone or with partners for extended sessions (often lasting 12–48 hours), neglecting hygiene, sleep, and nutrition, and experiencing intense cravings between episodes. Physiologically, chronic use of stimulants like crystal meth can lead to severe weight loss, dental decay (“meth mouth”), cardiovascular strain, and increased risk of sexually transmitted infections due to impaired judgement. Psychologically, users may develop paranoia, depression, anxiety, and psychosis. Dual diagnosis is common: many individuals also have underlying trauma, anxiety disorders, or mood conditions. The impact on family and work life is profound—job loss, financial problems, and relationship breakdowns are frequent, yet the shame of disclosure often keeps individuals isolated.

Treatment for chemsex addiction in France must address both the substance use and the sexual context. EAC connects you with partner clinics offering a full spectrum of care, from medically supervised detoxification to residential and day programmes. Outpatient options are also available for those with less severe dependence or strong support networks. Evidence-based therapies form the core of treatment: Cognitive Behavioural Therapy (CBT) helps identify triggers linked to sexual situations; Dialectical Behaviour Therapy (DBT) builds distress tolerance; and EMDR can be effective for underlying trauma. Medication-Assisted Treatment (MAT) may be used for opioid-based chemsex drugs. Many clinics incorporate 12-step facilitation or SMART Recovery groups. All partner clinics operate with multilingual staff and are fully GDPR-compliant, ensuring your confidentiality is protected under French and EU law. Whether you are in Paris, Lyon, or a smaller city, we can find a suitable placement.

Treatment for chemsex addiction in France must address both the substance use and the sexual context. EAC connects you with partner clinics offering a full spectrum of care, from medically supervised detoxification to residential and day programmes. Outpatient options are also available for those with less severe dependence or strong support networks. Evidence-based therapies form the core of treatment: Cognitive Behavioural Therapy (CBT) helps identify triggers linked to sexual situations; Dialectical Behaviour Therapy (DBT) builds distress tolerance; and EMDR can be effective for underlying trauma. Medication-Assisted Treatment (MAT) may be used for opioid-based chemsex drugs. Many clinics incorporate 12-step facilitation or SMART Recovery groups. All partner clinics operate with multilingual staff and are fully GDPR-compliant, ensuring your confidentiality is protected under French and EU law. Whether you are in Paris, Lyon, or a smaller city, we can find a suitable placement.

Our process is designed to be straightforward and supportive:

1. 1. Free confidential assessment: Contact us by phone or online. A specialist will speak with you the same day, in English or French, to understand your situation.
2. 2. Personalised treatment plan: Based on your assessment, we develop a plan with a consultant psychiatrist or addiction specialist, considering dual diagnosis if present.
3. 3. Placement and admission: We match you with an accredited partner clinic in France that suits your clinical needs, location preference, and budget. Admission typically occurs within 48–72 hours.
4. 4. Treatment programme: Residential programmes for chemsex typically last 28 to 90 days, depending on severity. Therapy is intensive and structured.
5. 5. Aftercare and relapse prevention: Before discharge, a detailed plan is created, including local support groups, outpatient therapy, and relapse prevention strategies, coordinated with your referring doctor.